journal
preproof
j
u
r
n
l
p
r
e
p
r
f
acknowledg
novel
coronaviru
diseas
caus
caus
agent
potenti
fatal
diseas
great
global
public
health
concern
outbreak
wreak
havoc
worldwid
due
inadequ
risk
assess
regard
urgenc
situat
pandem
enter
danger
new
phase
compar
sar
mer
spread
rapidli
due
increas
global
adapt
viru
everi
environ
slow
spread
case
significantli
reduc
strain
healthcar
system
countri
limit
number
peopl
sever
sick
need
hospit
care
henc
recent
outburst
highlight
urgent
need
therapeut
target
discuss
structur
viru
vari
symptom
among
sar
mer
common
flu
probabl
mechan
behind
infect
immun
respons
current
treatment
option
drug
avail
ongo
trial
recent
diagnost
discuss
suggest
tradit
indian
medicin
plant
possibl
novel
therapeut
approach
exclus
target
pathway
speci
head
enzoot
speci
infect
human
schoeman
field
current
seven
human
cov
hcov
confirm
specif
name
human
coronaviru
human
coronaviru
belong
alphacoronaviru
genu
wherea
human
coronaviru
human
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
belong
betacoronaviru
genu
strain
coronaviru
caus
mild
respiratori
diseas
human
zoonot
viru
belong
coronavirida
famili
infect
human
sever
anim
speci
belong
subgenu
sarbecoviru
mostli
resembl
bat
coronaviru
share
sequenc
homolog
chan
et
al
current
thought
introduc
human
unidentifi
intermediari
anim
spread
humantohuman
human
coronavirus
predominantli
concomit
upper
respiratori
tract
ill
rang
mild
moder
includ
common
cold
peopl
may
infect
one
virus
point
lifetim
killerbi
et
al
sarscov
merscov
two
major
caus
sever
pneumonia
human
song
et
al
compar
analysi
symptom
among
sar
mer
common
flu
explain
world
observ
sudden
emerg
exact
origin
viru
continu
remain
mysteri
research
worldwid
investig
need
carri
pinpoint
exact
sourc
infect
februari
offici
name
viral
diseas
guarner
coronaviru
studi
group
intern
j
u
r
n
l
p
r
e
p
r
f
committe
taxonomi
virus
name
new
pathogen
gorbalenya
predecessor
sarscov
first
emerg
cours
infect
death
record
infect
spread
across
countri
peiri
et
al
close
follow
emerg
merscov
saudi
arabia
caus
death
among
known
infect
case
zaki
et
al
similar
anteced
appear
decemb
anim
kingdom
spread
human
popul
known
show
symptom
slowli
incub
period
around
week
time
viru
replic
upper
lower
respiratori
tract
form
lesion
chan
et
al
gener
symptom
observ
infect
individu
fever
cough
dyspnoea
lesion
lung
advanc
stage
symptom
viru
show
pneumonia
progress
sever
pneumonia
acut
respiratori
distress
syndrom
ard
result
need
lifesupport
sustain
patient
life
heymann
shindo
belong
largest
famili
rna
virus
genom
rang
kilobas
size
nanomet
micron
singl
strand
envelop
rna
viru
possess
positivesens
rna
genom
also
known
ssrna
structur
tail
chen
j
u
r
n
l
p
r
e
p
r
f
import
one
n
former
one
help
viru
develop
capsid
entir
viral
structur
appropri
later
one
help
attach
viru
host
cell
siu
et
al
wall
et
al
protein
three
major
section
larg
ectodomain
singlepass
transmembran
anchor
short
intracellular
tail
play
major
role
anchor
host
cell
among
section
ectodomain
two
subunit
receptorbind
subunit
membran
fusion
subunit
subunit
clovetrimer
crown
structur
reason
coronaviru
corona
crown
got
name
zumla
et
al
report
sarscov
similar
kind
receptor
especi
receptor
bind
domain
rbd
receptor
bind
motif
rbm
viral
genom
yin
wunderink
zhang
et
al
tai
et
al
sar
infect
rbm
protein
get
directli
attach
angiotensionconvert
enzym
human
host
cell
phan
protein
express
variou
organ
human
bodi
mainli
lung
kidney
intestin
prime
target
coronaviru
gain
recognit
signific
regul
physiolog
patholog
reproduct
system
pan
et
al
although
due
novel
natur
viru
studi
proven
reduc
men
fertil
sexual
potenc
medic
wuhan
suggest
likelihood
diseas
affect
product
sperm
lead
low
sperm
count
format
male
sex
hormon
low
libido
addit
infect
host
cell
receptor
lead
relat
pneumonia
also
caus
acut
myocardi
injuri
chronic
damag
cardiovascular
system
interestingli
also
propos
mechan
action
infect
human
similar
sar
report
rbm
major
amino
acid
residu
favour
attach
fusion
viral
protein
viru
protein
human
cell
especi
one
present
lung
result
respiratori
infect
human
yin
wunderink
illustr
structur
bind
protein
depict
simplest
direct
approach
combat
would
neutral
viru
enter
cell
util
previou
virus
kind
walker
burton
key
advantag
host
protein
chang
fear
advantag
mutat
may
hinder
drug
develop
karaku
et
al
find
suggest
indepth
knowledg
receptor
target
basi
viral
replic
would
step
stone
find
remedi
infect
viru
enter
human
host
cell
next
step
surviv
rna
replic
viral
rna
replic
unusu
critic
step
carri
viru
surviv
insid
host
bodi
tool
requir
process
replic
open
read
frame
orf
two
replicas
gene
slipperi
sequenc
two
polyprotein
polyprotein
contain
import
protein
viru
nsp
protein
protein
common
occurr
viru
type
baranov
et
al
recent
found
nsp
protein
vital
role
replic
also
attack
immun
system
host
viral
replic
youngchang
et
al
j
u
r
n
l
p
r
e
p
r
f
nsp
protein
assembl
form
replicasetranscriptas
complex
rtc
creat
environ
insid
host
bodi
suitabl
rna
synthesi
replic
also
nsp
variou
role
rna
replic
viru
code
rnadepend
rna
polymeras
rdrp
domain
encrypt
rna
helicas
domain
rna
encod
exoribonucleas
exon
help
replic
conform
final
encod
activ
evid
prove
nsp
protein
vital
role
keep
viru
aliv
insid
host
bodi
promot
basic
synthesi
replic
translat
process
replic
similar
sarscov
viru
multifacet
need
understand
fehr
perlman
zhang
et
al
replic
genom
rna
contain
end
region
untransl
leader
l
sequenc
transcript
regul
sequenc
tr
present
descend
region
genom
brian
baric
replicas
gene
encod
enzym
use
neg
rna
genom
templat
develop
set
small
overlap
messeng
rna
mrna
molecul
get
translat
structur
protein
viz
n
e
protein
also
known
build
block
product
new
viral
particl
insid
host
bodi
posit
strand
rna
genom
use
templat
produc
neg
strand
replic
process
insid
human
host
n
protein
viru
bind
genom
protein
associ
membran
endoplasm
reticulum
er
help
nsp
protein
rna
get
assembl
helic
twist
structur
bud
er
lumen
viral
progeni
transfer
cell
membran
golgi
bodi
exocytos
extracellular
space
human
host
cell
environ
mechan
j
u
r
n
l
p
r
e
p
r
f
discov
preced
virus
may
pivot
role
well
brian
baric
de
haan
rottier
replic
process
evid
target
nsp
protein
could
enabl
us
develop
strategi
overcom
viral
infect
replic
pathway
associ
viru
also
target
drug
develop
share
homolog
sarscov
rate
transmiss
infect
remark
acceler
spread
rate
may
due
gain
function
mutat
make
novel
viru
differ
sarscov
viru
chang
found
includ
absent
longer
shorter
segment
differ
nsp
protein
nsp
consist
mutat
probabl
associ
abil
viru
contagi
angeletti
et
al
addit
protein
also
differ
may
benefici
understand
biolog
function
protein
found
pathogen
virus
contain
furin
like
cleavag
site
protein
present
sarscov
present
coutard
et
al
may
reason
increas
virul
moreov
bind
receptor
sarscov
name
much
higher
strength
could
reason
increas
transmiss
rate
capac
affect
speci
eas
protein
n
termin
c
termin
rbd
present
region
domain
protein
consist
fusion
protein
second
proteolyt
site
follow
intern
fusion
peptid
fp
two
heptadrepeat
domain
preced
transmembran
domain
tm
j
u
r
n
l
p
r
e
p
r
f
intern
fp
ident
sarscov
coutard
et
al
previou
studi
suggest
might
similar
mechan
like
sarscov
enter
host
cell
like
betacoronavirus
undergo
step
enter
affect
host
cell
bind
receptor
present
respiratori
epithelium
alveoli
lung
sarscov
upon
bind
receptor
proteas
recruit
cleav
protein
domain
cleavag
induc
conform
chang
activ
follow
insert
fp
membran
membran
fusion
occur
facilit
entri
viru
cell
sinc
nucleotid
conserv
rbd
bind
motif
associ
possibl
util
mechan
well
viru
enter
cell
get
cleav
shed
extra
membran
space
reduc
known
concomit
alveoli
injuri
increas
pulmonari
vascular
permeabl
li
clercq
could
due
convers
angiotensin
angiotensin
ii
neg
regul
reninangiotensin
pathway
angiotensin
ii
stimul
atir
result
lung
patholog
associ
respiratori
distress
li
clercq
viru
translat
protein
cell
protein
produc
code
ca
ion
channel
similar
sarscov
interact
activ
transcript
nfkb
pathway
result
transcript
j
u
r
n
l
p
r
e
p
r
f
protein
also
activ
inflammasom
pathway
protein
longer
extra
nucleotid
present
viru
need
studi
figur
caus
ad
advantag
e
protein
form
ion
channel
also
conserv
two
virus
involv
overproduct
cytokin
inflammasom
pathway
nietotorr
et
al
pathway
combin
togeth
caus
cytokin
storm
result
respiratori
distress
common
symptom
anoth
pathway
involv
sarscov
includ
jnk
pathway
activ
may
lead
increas
product
proinflammatori
factor
escal
lung
damag
liu
et
al
jnk
pathway
also
consid
target
also
involv
protein
analog
virus
infect
viru
import
part
interact
host
cell
nucleas
possibl
may
use
proteas
similar
sarscov
trypsin
plasmin
cathepsin
l
furin
cleavag
spike
protein
viru
enter
cell
proteas
use
target
reduc
symptom
proteasom
inhibitor
use
hiv
treatment
use
treatment
target
may
advantag
understand
involv
immun
system
explor
possibl
develop
specif
vaccin
elucid
previou
virus
simmon
et
al
hcov
gener
long
bp
positivesens
singlestrand
rna
virus
two
group
protein
character
hcov
structur
protein
nonstructur
protein
rna
depend
rna
polymeras
rdrp
j
u
r
n
l
p
r
e
p
r
f
elfiki
could
use
treatment
infect
ultim
need
clinic
trial
delin
specif
side
effect
treatment
kruse
therefor
might
play
import
role
treatment
function
inhibit
kruse
immunolog
studi
show
crucial
understand
basic
immun
respons
virus
immun
cell
induc
attack
viru
increas
specif
besid
immun
system
scientist
also
found
possibl
involv
nervou
system
alway
confin
respiratori
tract
also
invad
central
nervou
system
cn
induc
neurolog
diseas
coronavirus
potenti
betacoronavirus
includ
sarscov
glass
et
al
merscov
li
et
al
talbot
et
al
et
al
mous
hepat
viru
mhv
zhou
et
al
porcin
hemagglutin
encephalomyel
viru
phev
mengel
et
al
accord
previou
studi
coronavirus
may
initi
invad
peripher
nerv
enter
cn
via
synapt
rout
transsynapt
transfer
document
avian
bronchiti
viru
matsuda
et
al
first
coronaviru
found
invad
porcin
brain
hev
share
homolog
li
et
al
therefor
neuroinvas
propens
demonstr
common
featur
coronavirus
sinc
high
similar
sarscov
quit
like
may
also
possess
analog
potenti
base
epidemiolog
j
u
r
n
l
p
r
e
p
r
f
survey
first
symptom
dyspnea
occur
day
follow
hospit
admiss
day
intens
care
day
latenc
period
enough
viru
enter
destroy
medullari
neuron
possibl
mechan
entri
insid
cn
illustr
similarli
mathew
state
symptom
might
attribut
respiratori
diseas
due
inabl
air
get
lung
might
actual
defect
respir
control
nervou
system
report
patient
show
neurolog
sign
includ
headach
nausea
vomit
neuroinvas
accompani
respiratori
failur
patient
entri
viru
cn
must
prevent
emerg
viru
awar
possibl
entri
cn
signific
prevent
treatment
also
import
find
effect
antivir
drug
cross
bloodbrain
barrier
therefor
innov
approach
requir
detect
viral
infect
earlier
period
sar
mer
outbreak
effect
diagnost
tool
develop
accur
detect
although
use
time
essenti
develop
specif
test
viral
nucleic
acid
detect
primarili
use
diagnosi
cdc
recommend
collect
upper
respiratori
nasopharyng
np
swab
diagnost
test
cdc
cdc
detect
assay
target
n
region
consist
one
test
betacoronavirus
two
uniqu
probe
algorithm
compris
probe
e
protein
radepend
rna
polymeras
rdrp
posit
sampl
test
specif
sarsj
u
r
n
l
p
r
e
p
r
f
rdrp
loeffelholz
tang
contrastingli
e
protein
rdrp
also
detect
sarscov
assay
use
test
trace
sarscov
cord
heim
commerci
avail
real
star
kit
viru
rox
vial
kit
super
script
iii
onestep
rtpcr
system
platinum
taqdna
polymeras
compar
effici
realstar
kit
unwant
signal
exceed
two
perform
konrad
et
al
method
also
compromis
due
inadequ
sampl
volum
inaccuraci
method
test
collect
sampl
appropri
time
window
contamin
similar
issu
identifi
potenti
problem
may
diminish
precis
test
lippi
et
al
moreov
test
also
expens
henc
cheaper
altern
develop
track
symptom
use
smartphon
surveil
dorigatti
et
al
imag
techniqu
also
util
diagnost
method
addit
chest
ct
scan
facilit
detect
lung
abnorm
infect
abnorm
ct
scan
concomit
diseas
progress
prognosi
case
perfectli
detect
ct
scan
lei
et
al
therefor
essenti
conduct
molecular
test
consid
travel
histori
clinic
symptom
patient
well
upsurg
infect
peopl
effici
quicker
cheaper
diagnost
tool
must
develop
effect
identifi
infect
individu
henc
integr
approach
imag
molecular
diagnosi
would
help
screen
treat
covid
effect
order
design
specif
drug
import
understand
current
strategi
use
treat
novel
though
number
affect
individu
constantli
rise
fda
approv
drug
yet
present
treatment
provid
affect
individu
mainli
symptom
base
serious
ill
individu
provid
organ
support
jin
et
al
zumla
et
al
necessari
invest
time
effort
identifi
vaccin
drug
novel
viru
sinc
develop
drug
specif
covid
take
least
month
drug
proven
safe
human
repurpos
treat
diseas
vast
major
drug
use
treatment
worldwid
fall
follow
classif
drug
antiinflammatori
drug
especi
jakstat
inhibitor
use
rheumatoid
arthriti
may
effect
elev
level
cytokin
use
inhibit
viral
infect
accord
recent
studi
inflammatori
drug
baricitinib
use
combin
antivir
drug
like
remidesivir
increas
potenti
drug
reduc
viral
infect
viru
known
enter
host
cell
bind
protein
receptor
develop
neutral
antibodi
receptor
high
possibl
reduc
sever
diseas
zheng
song
current
hand
drug
approv
use
even
declar
pandem
immens
lack
diseas
specif
drug
rapidli
spread
viru
essenti
provid
time
treatment
affect
individu
zumla
et
al
list
potenti
drug
provid
tabl
commonli
use
drug
discuss
ribavirin
ribavirin
also
broadspectrum
drug
whose
therapeut
potenti
uncov
antivir
drug
use
treatment
hepat
c
usual
use
combin
interferon
ifn
drug
approv
nucleotid
analog
use
treatment
ebola
sarscov
merscov
promis
potenti
drug
caus
prematur
termin
enter
nascent
viral
rna
warren
et
al
current
undergo
clinic
trial
ebola
treatment
mulangu
et
al
anoth
recent
studi
shown
remidesivir
score
half
maxim
concentr
block
viral
infect
chloroquin
drug
classifi
antimalari
drug
shown
potenti
treatment
avian
influenza
yan
et
al
chloroquin
also
shown
antivir
well
immun
modul
properti
drug
also
show
half
maxim
concentr
block
viral
infect
increas
endosom
ph
requir
viral
fusion
vincent
et
al
j
u
r
n
l
p
r
e
p
r
f
favipiravir
drug
also
broad
spectrum
antivir
drug
obtain
approv
shenzan
health
commiss
treat
patient
current
numer
compani
appli
clinic
trial
repurpos
exist
drug
well
develop
vaccin
drug
fight
fast
spread
rudra
et
al
case
repurpos
exist
drug
random
control
treatment
rct
carri
variou
biotechnolog
compani
well
research
organ
nation
institut
health
nih
usa
identifi
diseas
specif
drug
major
drug
undergo
clinic
trial
potenti
treat
viral
infect
tabl
research
may
requir
tradit
medicin
util
treatment
indian
tradit
medicin
system
consid
one
oldest
treatment
human
histori
play
import
role
encount
global
health
care
need
ravishankar
shukla
tradit
indian
medicin
practic
includ
ayurveda
siddha
unani
yoga
naturopathi
homoeopathi
success
practic
treat
variou
diseas
gomathi
et
al
practic
came
exist
year
ago
system
wit
script
ancient
literatur
tradit
indian
medicin
use
plant
miner
anim
product
cure
human
diseas
tradit
knowledg
regard
plant
sourc
usag
essenti
use
accur
right
condit
tabuti
et
al
plant
base
formul
use
folk
remedi
j
u
r
n
l
p
r
e
p
r
f
indian
medicin
pundarikakshudu
kanaki
recent
total
number
indian
medicin
plant
estim
around
yet
tradit
practition
use
around
differ
speci
practic
pundarikakshudu
kanaki
tradit
medicin
gener
ignor
research
develop
modern
drug
sinc
translat
potenti
often
underestim
although
medicin
ambigu
wide
context
usag
nonwestern
medic
technolog
yuan
et
al
singl
herb
may
contain
mani
phytochem
constitu
function
alon
combin
compound
produc
desir
pharmacolog
effect
parasuraman
et
al
due
use
tradit
medicin
mani
plant
molecul
studi
subsequ
modul
drug
variou
diseas
liweb
fabric
farnsworth
search
new
compound
antivir
activ
often
unsatisfactori
due
viral
resist
along
viral
latenc
recurr
infect
immunecompromis
patient
sumithira
et
al
among
antivir
therapeut
method
major
nonspecif
virus
jiang
et
al
sinc
ancient
time
indian
herb
use
treatment
prevent
strategi
sever
diseas
includ
respiratori
viral
infect
benefit
use
herb
viral
respiratori
infect
build
immun
stimul
inflamm
modul
effect
manag
immun
system
holist
approach
ayush
system
medicin
give
focu
prevent
lifestyl
modif
dietari
manag
prophylact
intervent
improv
immun
simpl
remedi
base
present
symptom
ayush
indian
prevent
prophylact
medicin
plant
recommend
ayush
tabl
also
studi
coronaviru
use
medicin
plant
rather
minim
india
studi
shown
antimous
coronavir
activ
evolvulu
alsinoid
tamil
nadu
vimalanathan
et
al
among
vitex
trifolia
sphaeranthu
indicu
found
reduc
inflammatori
cytokin
use
nfkb
pathway
pathway
implic
respiratori
distress
sarscov
alam
et
al
srivastava
et
al
clitoria
ternatea
j
u
r
n
l
p
r
e
p
r
f
identifi
metalloproteinas
inhibitor
metalloproteinas
involv
ace
shred
target
use
plant
shred
associ
increas
format
virus
maiti
et
al
plant
glycyrrhiza
glabra
nourazarian
allium
sativum
keyaert
et
al
known
target
viral
replic
sarscov
aris
promis
candid
clerodendrum
inerm
gaertn
anoth
herb
found
potenti
inactiv
viral
ribosom
investig
util
drug
target
protein
translat
olivieri
et
al
similarli
strobilanth
cusia
tsai
et
al
verbascum
thapsu
reduc
infect
caus
influenza
virus
molecular
mechan
plant
target
influenza
viru
studi
understand
attack
molecul
overlap
influenza
virus
hyoscyamu
niger
found
bronchodil
also
inhibitori
effect
ca
channel
gilani
et
al
could
use
target
ca
channel
trigger
variou
downstream
pathway
upon
viral
infect
importantli
variou
medicin
plant
shown
inhibitori
effect
ace
includ
coriandrum
sativum
hussain
et
al
yarnel
arora
et
al
coon
ernst
note
andrographi
paniculata
suppress
increas
nodlik
receptor
protein
molecul
extens
involv
pathogenesi
sarscov
like
well
salacia
oblonga
et
al
anoth
plant
tamil
nadu
also
display
suppress
effect
angiotensin
ii
signal
relat
lung
damag
promis
drug
includ
acacia
nilotica
shanti
eugenia
jambolana
otak
et
al
euphorbia
granul
shanti
plant
like
ocimum
sanctum
rege
chowdhari
ocimumkilim
scharicum
thayil
seema
thyagarajan
solanum
nigrum
yu
vitex
negundo
nair
known
target
revers
transcriptas
activ
hiv
studi
activ
well
sambucu
ebulu
ganjhu
et
al
known
inhibit
activ
envelop
virus
also
use
target
viru
medicin
plant
use
amelior
symptom
though
mani
medicin
plant
identifi
lot
research
carri
develop
drug
specif
therefor
import
explor
effect
prescrib
tradit
medicin
emerg
danger
pandem
threat
throughout
globe
sinc
outbreak
decemb
becom
big
challeng
research
virologist
find
solut
deadli
diseas
attribut
fact
viral
infect
known
fastest
frequenc
recombin
replic
posit
strand
result
quick
format
new
progeni
viral
cell
insid
host
cell
also
report
high
rate
mutagenesi
chang
structur
creat
barrier
investig
diseas
therapeut
regimen
american
societi
microbiolog
recent
research
identifi
mainli
two
type
strain
l
strain
among
strain
l
strain
common
may
evolv
strain
addit
l
strain
higher
rate
replic
insid
human
host
cell
result
escal
infect
limit
time
henc
becom
big
challeng
analyz
condit
offer
therapi
short
time
avail
due
high
mutat
rate
harder
understand
genom
organ
host
interact
viru
habibzadeh
stoneman
genom
structur
viru
factor
present
great
challeng
research
abil
adapt
surviv
differ
environment
condit
make
nearli
imposs
identifi
mode
surviv
earlier
report
sar
viru
surviv
humid
rate
first
outbreak
peak
winter
environment
temperatur
around
sinc
viru
past
decad
urg
discov
root
caus
coronaviru
infect
anim
human
well
current
emerg
intens
petrifi
viral
infect
handl
human
race
accord
major
concern
among
public
health
analyz
understand
role
nonstructur
accessori
protein
encrypt
viru
aid
us
understand
mechan
action
also
acquir
indepth
framework
uniqu
rna
replic
process
enabl
us
find
breakthrough
point
understand
host
immunolog
respons
review
suggest
import
indian
medicin
plant
use
sever
decad
treatment
variou
respiratori
condit
highlight
pathway
plantbas
medicin
may
target
reduc
diseas
burden
thu
proactiv
invest
research
base
indian
medicin
plant
deriv
vaccin
drug
treat
would
emerg
sourc
light
overcom
fatal
infect
case
report
mani
part
china
outbreak
involv
larg
settl
surfac
environ
infect
peopl
breath
particl
touch
place
touch
bodi
part
henc
import
stay
meter
feet
away
person
sick
report
suggest
older
person
person
preexist
medic
condit
high
blood
pressur
heart
diseas
lung
diseas
cancer
diabet
appear
develop
seriou
ill
often
other
also
pregnant
women
infect
pass
infect
unborn
babi
wu
mcgoogan
chen
et
al
also
report
asian
popul
suscept
acquir
infect
compar
race
popul
xu
follow
protect
measur
given
among
viral
structur
protein
major
role
bind
viru
host
receptor
cell
protein
two
subunit
receptorbind
subunit
membran
fusion
subunit
earlier
one
attach
receptor
human
host
cell
subunit
internalis
creat
membran
fusion
among
viral
subunit
receptor
lead
releas
viral
rna
host
cell
result
respiratori
infect
possibl
mechan
action
depict
bind
receptor
subunit
subsequ
cleav
follow
shed
adam
result
increas
amount
angiotensin
ii
lead
respiratori
distress
upon
bind
viru
fuse
membran
enter
cell
follow
translat
replic
protein
e
protein
nfkb
pathway
activ
inflammasom
pathway
variou
mean
lead
activ
cytokin
result
cytokin
storm
result
respiratori
distress
entri
human
coronaviru
cn
olfactori
bulb
upon
nasal
infect
caus
inflamm
demyelin
reach
whole
brain
via
blood
brain
barrier
csf
via
bloodcsf
barrier
day
possibl
entri
brain
cn
import
design
effect
antivir
drug
effect
drug
may
cross
blood
brain
barrier
blood
csf
barrier
may
taken
consider
design
could
promis
treatment
strategi
j
u
r
n
l
p
r
e
p
r
f
j
u
r
n
l
p
r
e
p
r
f
j
u
r
n
l
p
r
e
p
r
f
diao
et
al
interferon
subtyp
human
leukocyt
interferon
sar
tan
et
al
acyclovir
sar
mer
coronaviru
peter
et
al
cathespin
l
sar
simmon
et
al
